Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00533650

Enrollment

227

Registered

2007-09-21

Start date

2000-12-31

Completion date

2002-10-31

Last updated

2016-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Menopausal Osteoporosis

Brief summary

A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.

Interventions

DRUGMK0429

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis

Exclusion criteria

* Person has had a previous fracture * Person has rheumatoid arthritis. Person has has certain types of cancer * Person has donated blood or has been in another investigational study within the last 4 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026